|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 16 of 23 found articles
| Title: |
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial |
| Author: |
Bateman, Randall J Li, Yan McDade, Eric M Llibre-Guerra, Jorge J Clifford, David B Atri, Alireza Mills, Susan L Santacruz, Anna M Wang, Guoqiao Supnet, Charlene Benzinger, Tammie L S Gordon, Brian A Ibanez, Laura Klein, Gregory Baudler, Monika Doody, Rachelle S Delmar, Paul Kerchner, Geoffrey A Bittner, Tobias Wojtowicz, Jakub Bonni, Azad Fontoura, Paulo Hofmann, Carsten Kulic, Luka Hassenstab, Jason Aschenbrenner, Andrew J Perrin, Richard J Cruchaga, Carlos Renton, Alan E Xiong, Chengjie Goate, Alison A Morris, John C Holtzman, David M Snider, B Joy Mummery, Catherine Brooks, William S Wallon, David Berman, Sarah B Roberson, Erik Masters, Colin L Galasko, Douglas R Jayadev, Suman Sanchez-Valle, Rachel Pariente, Jeremie Kinsella, Justin van Dyck, Christopher H Gauthier, Serge Hsiung, Ging-Yuek Robin Masellis, Mario Dubois, Bruno Honig, Lawrence S Jack, Clifford R Daniels, Alisha Aguillón, David Allegri, Ricardo Chhatwal, Jasmeer Day, Gregory Fox, Nick C Huey, Edward Ikeuchi, Takeshi Jucker, Mathias Lee, Jae-Hong Levey, Allan I Levin, Johannes Lopera, Francisco Roh, JeeHoon Rosa-Neto, Pedro Schofield, Peter R |
| Appeared in: |
The lancet neurology |
| Paging: | Volume 24 () nr. 4 pages 316-330 |
| Year: |
2025 |
| Contents: | |
| Publisher: |
Elsevier Ltd |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 16 of 23 found articles
| << previous | next >> |